DMC Group’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,910
Closed -$467K 141
2026
Q1
$467K Buy
+1,910
New +$445K 0.32% 87
2023
Q4
Sell
-2,330
Closed -$363K 125
2023
Q3
$363K Sell
2,330
-3,391
-59% -$560K 0.34% 81
2023
Q2
$947K Buy
5,721
+291
+5% +$47K 0.95% 32
2023
Q1
$852K Buy
5,430
+10
+0.2% +$1.61K 0.86% 37
2022
Q4
$966K Sell
5,420
-161
-3% -$27.8K 1.09% 22
2022
Q3
$911K Sell
5,581
-215
-4% -$36.4K 1.1% 21
2022
Q2
$1.03M Sell
5,796
-275
-5% -$49K 1.23% 19
2022
Q1
$1.1M Sell
6,071
-1,395
-19% -$237K 1.23% 17
2021
Q4
$1.27M Buy
+7,466
New +$1.22M 1.1% 24

Other funds holding JNJ

DMC Group's JNJ Position: Q2 2026 in Review

DMC Group sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 1,910 shares — an estimated $467K sold.

DMC Group first reported a position in JNJ in Q4 2021 and held it in 9 quarters. The position peaked at $1.27M in Q4 2021. 4,677 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • DMC Group reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
  • DMC Group sold 1,910 Johnson & Johnson shares in Q2 2026, an estimated $467K.
  • DMC Group first reported a position in Johnson & Johnson in Q4 2021 and held it in 9 quarters.
  • DMC Group's Johnson & Johnson position peaked at $1.27M in Q4 2021.
  • 4,677 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on DMC Group's 13F filing for Q2 2026, filed 28 Jul 2026.